Premium Nahrungsergänzungsmittel | artgerecht

Fetuin A – Function, Role & Biomarker

Fetuin A is a protein produced mainly by the liver that plays a key role in inhibiting abnormal calcium deposits in soft tissues and in regulating metabolic processes.

Regular tips about health Regular tips about health

Things worth knowing about "Fetuin A"

Fetuin A is a protein produced mainly by the liver that plays a key role in inhibiting abnormal calcium deposits in soft tissues and in regulating metabolic processes.

What is Fetuin A?

Fetuin A (also written as Fetuin-A) is a glycoprotein – a protein molecule linked to sugar chains – that is primarily produced in the liver and secreted into the bloodstream. It belongs to the cystatin superfamily of proteins and is scientifically known as Alpha-2-Heremans-Schmid glycoprotein (AHSG). Fetuin A is detectable in blood serum and fulfills a wide range of regulatory roles in the body.

Biological Functions

Fetuin A performs several important functions in the body:

Inhibition of calcification: Fetuin A is one of the most potent natural inhibitors of ectopic calcification – the abnormal deposition of calcium salts in soft tissues such as blood vessels, kidneys, and heart valves. It binds calcium and phosphate molecules, preventing them from crystallizing in tissues where they do not belong.
Inhibition of insulin signaling: Fetuin A can impair the action of insulin at the cellular level. It blocks the insulin receptor and is associated with insulin resistance and the development of type 2 diabetes.
Modulation of inflammation: Fetuin A plays a role in regulating inflammatory processes. Depending on the context, it can both promote and suppress inflammatory responses.
Promotion of fat storage: Fetuin A facilitates the uptake of fatty acids into adipose (fat) tissue and is associated with the metabolic syndrome and non-alcoholic fatty liver disease (NAFLD).
Bone development and remodeling: Fetuin A also influences bone metabolism by inhibiting enzymes involved in bone formation.

Fetuin A and Disease

Cardiovascular Disease

Elevated levels of Fetuin A in the blood have been associated with an increased risk of atherosclerosis (hardening of the arteries) and heart disease. Paradoxically, low Fetuin A levels in patients with chronic kidney disease can also be a risk factor for vascular calcification, as the protective function against calcium deposits is diminished.

Type 2 Diabetes and Insulin Resistance

Numerous studies have shown that elevated Fetuin A concentrations in the blood are linked to reduced insulin sensitivity. Fetuin A inhibits the insulin receptor signaling pathway, thereby contributing to insulin resistance, which is recognized as a precursor to type 2 diabetes.

Non-Alcoholic Fatty Liver Disease (NAFLD)

Since Fetuin A is synthesized in the liver, altered Fetuin A levels often reflect the condition of the liver. In fatty liver disease, Fetuin A production is frequently elevated, which in turn can promote inflammation and worsen insulin resistance.

Chronic Kidney Disease

Patients with chronic kidney disease often have low Fetuin A levels. Since Fetuin A normally prevents calcification of blood vessels, a deficiency significantly increases the risk of vascular and heart valve calcification in these patients.

Fetuin A as a Biomarker

In modern medicine, Fetuin A is increasingly being used as a biomarker – a measurable indicator that reflects health status or disease risk. Measuring Fetuin A levels in the blood can provide insights into the following conditions:

Risk for type 2 diabetes
Degree of insulin resistance
Severity of fatty liver disease
Risk of cardiovascular calcification in kidney disease patients

Fetuin A and Nutrition

Studies suggest that certain dietary habits can influence Fetuin A levels. A high-calorie diet, particularly one rich in saturated fats and sugar, can increase Fetuin A production. Conversely, weight loss and adherence to a Mediterranean-style diet have been shown to lower Fetuin A levels, potentially reducing the risk of metabolic diseases.

References

Ix, J. H. & Sharma, K. (2010). Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. Journal of the American Society of Nephrology, 21(3), 406–412.
Stefan, N. et al. (2008). Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes, 57(10), 2762–2767.
Ketteler, M. et al. (2003). Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis. The Lancet, 361(9360), 827–833.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.